VERTEX PHARMACEUTICALS INC / MA Net Income 2008-2025 | VRTX
What is net income?
Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.
What is VERTEX PHARMACEUTICALS INC / MA's current net income?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual net income for 2025 was $3.95B, a 838.09% increase from 2024. VERTEX PHARMACEUTICALS INC / MA net income for the quarter ending December 31, 2025 was $1.19B.
What was VERTEX PHARMACEUTICALS INC / MA's net income in 2024?
VERTEX PHARMACEUTICALS INC / MA annual net income for 2024 was $-535.6M, a 114.80% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's net income in 2023?
VERTEX PHARMACEUTICALS INC / MA annual net income for 2023 was $3.62B, a 8.96% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year net income CAGR?
VERTEX PHARMACEUTICALS INC / MA net income grew at a compound annual growth rate (CAGR) of 7.83% from FY2020 to FY2025, going from $2.71B to $3.95B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.95B | +838.1% | 10-K |
| FY2024 | $-535.6M | -114.8% | 10-K |
| FY2023 | $3.62B | +9.0% | 10-K |
| FY2022 | $3.32B | +41.8% | 10-K |
| FY2021 | $2.34B | -13.6% | 10-K |
| FY2020 | $2.71B | +130.4% | 10-K |
| FY2019 | $1.18B | -43.9% | 10-K |
| FY2018 | $2.10B | +695.8% | 10-K |
| FY2017 | $263.5M | +335.1% | 10-K |
| FY2016 | $-112.1M | +79.9% | 10-K |
| FY2015 | $-556.3M | +24.7% | 10-K |
| FY2014 | $-738.6M | -66.0% | 10-K |
| FY2013 | $-445.0M | -315.8% | 10-K |
| FY2012 | $-107.0M | -461.9% | 10-K |
| FY2011 | $29.6M | +103.9% | 10-K |
| FY2010 | $-754.6M | -17.5% | 10-K |
| FY2009 | $-642.2M | -39.6% | 10-K |
| FY2008 | $-459.9M | - | 10-K |